Literature DB >> 32803366

Neonatal curcumin treatment restores hippocampal neurogenesis and improves autism-related behaviors in a mouse model of autism.

Hongyu Zhong1, Rui Xiao1, Ruotong Ruan1, Hui Liu1, Xin Li1, Yun Cai1, Jinghui Zhao1, Xiaotang Fan2,3.   

Abstract

RATIONALE: Autism spectrum disorders (ASDs) are highly prevalent neurodevelopmental disorders characterized by deficits in social communication and interaction, repetitive stereotyped behaviors, and cognitive impairments. Curcumin has been indicated to be neuroprotective against neurological and psychological disorders. However, the role of curcumin in autistic phenotypes remains unclear.
OBJECTIVES: In the current study, we evaluated the effects of neonatal curcumin treatment on behavior and hippocampal neurogenesis in BTBRT+ltpr3tf/J (BTBR) mice, a model of autism.
METHODS: C57BL/6J (C57) and BTBR mouse pups were treated with 0.1% dimethyl sulfoxide (DMSO) or curcumin (20 mg/kg) from postnatal day 6 (P6) to P8. Neural progenitor cells (NPCs) in the hippocampal dentate gyrus (DG) were evaluated on P8, and neurogenesis was measured on P24 by immunofluorescence. A battery of behavioral tests was carried out when the mice were 8 weeks of age.
RESULTS: Neonatal curcumin treatment improved autism-related symptoms in BTBR mice, enhancing sociability, reducing repetitive behaviors, and ameliorating cognitive impairments. Furthermore, the suppression of hippocampal neurogenesis in BTBR mice was greatly rescued after neonatal curcumin treatment, leading to an increase in neurogenic processes and an increase in NPC proliferation concomitant with an expansion of the NPC pool on P8, and NPC differentiation towards the neuronal lineage was promoted in the DG of BTBR mice on P24.
CONCLUSIONS: Our findings suggest that neonatal curcumin treatment elicits a therapeutic response through the restoration of hippocampal neurogenesis in BTBR mice and thus may represent a promising novel pharmacological strategy for ASD treatment.

Entities:  

Keywords:  Autism; Cognition; Curcumin; Hippocampal neurogenesis; Repetitive behaviors; Sociability

Year:  2020        PMID: 32803366     DOI: 10.1007/s00213-020-05634-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  60 in total

1.  Autism-like behavior in the BTBR mouse model of autism is improved by propofol.

Authors:  Yulong Cai; Lian Wang; Rui Xiao; Xin Li; Xie He; Junwei Gao; Haiwei Xu; Xiaotang Fan
Journal:  Neuropharmacology       Date:  2017-03-21       Impact factor: 5.250

Review 2.  Benefits of curcumin in brain disorders.

Authors:  Abid Bhat; Arehally M Mahalakshmi; Bipul Ray; Sunanda Tuladhar; Tousif A Hediyal; Esther Manthiannem; Jagadeeswari Padamati; Ramesh Chandra; Saravana B Chidambaram; Meena K Sakharkar
Journal:  Biofactors       Date:  2019-06-11       Impact factor: 6.113

Review 3.  Neural basis of major depressive disorder: Beyond monoamine hypothesis.

Authors:  Shuken Boku; Shin Nakagawa; Hiroyuki Toda; Akitoyo Hishimoto
Journal:  Psychiatry Clin Neurosci       Date:  2017-10-19       Impact factor: 5.188

4.  Postnatal treatment using curcumin supplements to amend the damage in VPA-induced rodent models of autism.

Authors:  Maha Al-Askar; Ramesa Shafi Bhat; Manar Selim; Laila Al-Ayadhi; Afaf El-Ansary
Journal:  BMC Complement Altern Med       Date:  2017-05-10       Impact factor: 3.659

5.  Liver X receptor β regulates the development of the dentate gyrus and autistic-like behavior in the mouse.

Authors:  Yulong Cai; Xiaotong Tang; Xi Chen; Xin Li; Ying Wang; Xiaohang Bao; Lian Wang; Dayu Sun; Jinghui Zhao; Yan Xing; Margaret Warner; Haiwei Xu; Jan-Åke Gustafsson; Xiaotang Fan
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-05       Impact factor: 11.205

6.  Neuropsychopharmacotherapeutic efficacy of curcumin in experimental paradigm of autism spectrum disorders.

Authors:  Ranjana Bhandari; Anurag Kuhad
Journal:  Life Sci       Date:  2015-09-25       Impact factor: 5.037

Review 7.  Inflammatory profiles in the BTBR mouse: how relevant are they to autism spectrum disorders?

Authors:  Milo Careaga; Jared Schwartzer; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2014-06-14       Impact factor: 7.217

Review 8.  Are early visual behavior impairments involved in the onset of autism spectrum disorders? Insights for early diagnosis and intervention.

Authors:  Fabio Apicella; Valeria Costanzo; Giulia Purpura
Journal:  Eur J Pediatr       Date:  2020-01-04       Impact factor: 3.183

9.  Hippocampal subfield volumes in mood disorders.

Authors:  B Cao; I C Passos; B Mwangi; H Amaral-Silva; J Tannous; M-J Wu; G B Zunta-Soares; J C Soares
Journal:  Mol Psychiatry       Date:  2017-01-24       Impact factor: 15.992

10.  The Liver X Receptor Agonist TO901317 Ameliorates Behavioral Deficits in Two Mouse Models of Autism.

Authors:  Yulong Cai; Hongyu Zhong; Xin Li; Rui Xiao; Lian Wang; Xiaotang Fan
Journal:  Front Cell Neurosci       Date:  2019-05-14       Impact factor: 5.505

View more
  7 in total

1.  miR-92a-2-5p Regulates the Proliferation and Differentiation of ASD-Derived Neural Progenitor Cells.

Authors:  Wenting Zhuang; Hui Liu; Zhize He; Jielan Ju; Qiuxia Gao; Zhiyan Shan; Lei Lei
Journal:  Curr Issues Mol Biol       Date:  2022-05-24       Impact factor: 2.976

2.  GW4064 Alters Gut Microbiota Composition and Counteracts Autism-Associated Behaviors in BTBR T+tf/J Mice.

Authors:  Jiayin Liu; Chuanqi Liu; Zhanyuan Gao; Lianyu Zhou; Junwei Gao; Yi Luo; Tianyao Liu; Xiaotang Fan
Journal:  Front Cell Infect Microbiol       Date:  2022-06-22       Impact factor: 6.073

3.  Nrf2 Activators as Dietary Phytochemicals Against Oxidative Stress, Inflammation, and Mitochondrial Dysfunction in Autism Spectrum Disorders: A Systematic Review.

Authors:  Jiaxin Yang; Xi Fu; Xiaoli Liao; Yamin Li
Journal:  Front Psychiatry       Date:  2020-11-20       Impact factor: 4.157

Review 4.  Alteration of Gut Microbiota: New Strategy for Treating Autism Spectrum Disorder.

Authors:  Jiayin Liu; Zhanyuan Gao; Chuanqi Liu; Tianyao Liu; Junwei Gao; Yun Cai; Xiaotang Fan
Journal:  Front Cell Dev Biol       Date:  2022-03-03

Review 5.  An Update on the Exploratory Use of Curcumin in Neuropsychiatric Disorders.

Authors:  Nicolás Lamanna-Rama; Diego Romero-Miguel; Manuel Desco; Maria Luisa Soto-Montenegro
Journal:  Antioxidants (Basel)       Date:  2022-02-10

Review 6.  Repetitive Restricted Behaviors in Autism Spectrum Disorder: From Mechanism to Development of Therapeutics.

Authors:  Junbin Tian; Xuping Gao; Li Yang
Journal:  Front Neurosci       Date:  2022-03-02       Impact factor: 4.677

7.  Curcumin Potentiates α7 Nicotinic Acetylcholine Receptors and Alleviates Autistic-Like Social Deficits and Brain Oxidative Stress Status in Mice.

Authors:  Petrilla Jayaprakash; Dmytro Isaev; Waheed Shabbir; Dietrich E Lorke; Bassem Sadek; Murat Oz
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.